शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SHARDACROPBSESHARDA CROPCHEM LTD.· Fertilizers & AgrochemicalsMediumNeutral
Announced Fri, 6 Nov, 2026 · 11:49 IST

Q2 revenue and margins rise; FY27 growth guidance maintained

Management guided margin improvementInvestor Communications View source PDFExplain this filing

SHARDACROP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.8%Reaction day
₹682.35
prior close
₹671.70
announcement price
In-mkt
timing
Nifty Microcap 250marketpendingvs market: pending
Pesticides & Agrochemicals peers, median of 28sector-0.1%+1.0% vs sector

On the reaction day the stock moved 1.0 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
-0.1
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.8pendingpending-0.1+1.0
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27 revenue rose 13% to INR1,052 crore and profit after tax rose 23% to INR92 crore. Gross margin expanded to 35.9%, while EBITDA rose 18% to INR164 crore. H1 revenue grew 11%; the company was debt-free with INR846 crore cash. Management kept FY27 revenue growth guidance at 10% to 15%, expects EBITDA margin of 18% to 20%, and plans INR550 crore to INR600 crore capital spending. Europe stayed weak, while NAFTA and LATAM grew strongly.

Likely market impact

Positive: growth and margin guidance support earnings, but lower volumes, weak Europe and heavy registration spending remain risks.